NVAX Jan 2024 240.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 06:53AM EST. Market open.
| Previous close | 92.53 |
| Open | N/A |
| Bid | 123.50 |
| Ask | 133.50 |
| Strike | 240.00 |
| Expiry date | 2024-01-19 |
| Day's range | 92.53 - 92.53 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
- Motley Fool
Better Buy: Novavax or BioNTech Stock?
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
- Yahoo Finance
COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.
- Motley Fool
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Novavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years. Initial gains came as investors bet on Novavax's chances of bringing a coronavirus vaccine to market; declines occurred after the vaccine entered the market later than rival products did. Now, as we start a new year, you might be wondering what to do about Novavax.
© 2023 Yahoo. All rights reserved.
